title: Systemic arterial pressure and brachial arterial flow-mediated dilatation in young cardiac transplant recipients.
authors.affiliation: Department of Pediatrics, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, Michigan 48198-0204, USA. scottlim@umich.edu
authors.forename: D Scott
authors.initials: DS
authors.lastname: Lim
authors.forename: Carlen A
authors.initials: CA
authors.lastname: Gomez
authors.forename: Caren S
authors.initials: CS
authors.lastname: Goldberg
authors.forename: Dennis C
authors.initials: DC
authors.lastname: Crowley
authors.forename: Albert P
authors.initials: AP
authors.lastname: Rocchini
authors.forename: John R
authors.initials: JR
authors.lastname: Charpie
mesh_terms: D000293:Adolescent; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001783:Blood Flow Velocity / Q000187:drug effects / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D001916:Brachial Artery / Q000502:physiology*; D002648:Child; D002669:Child Welfare; D002675:Child, Preschool; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D016027:Heart Transplantation; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000503:physiopathology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008824:Michigan; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009569:Nitric Oxide / Q000652:urine; D011241:Prednisone / Q000627:therapeutic use; D016896:Treatment Outcome; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D007166:Immunosuppressive Agents; D009569:Nitric Oxide; D016572:Cyclosporine; D003404:Creatinine; D009173:Mycophenolic Acid; D011241:Prednisone